Travere Therapeutics
TVTX
TVTX
170 hedge funds and large institutions have $1.78B invested in Travere Therapeutics in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 23
0% more funds holding
Funds holding: 170 → 170 (0)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
170
Holding in Top 10
5
Calls
$9.19M
Puts
$2.44M
Top Buyers
| 1 | +$93.3M | |
| 2 | +$12.7M | |
| 3 | +$11M | |
| 4 |
FC
Finepoint Capital
Boston,
Massachusetts
|
+$11M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$10.3M |
Top Sellers
| 1 | -$41.5M | |
| 2 | -$20.2M | |
| 3 | -$11.8M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$8.83M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.23M |